SIR-Genetic factors have been generally implicated in the etiology of suicide, although the precise mechanism and amount of the genetic contribution are not yet well established. 1 The serotonergic system is thought to be trait dependent and associated with disturbances in the regulation of anxiety, impulsivity, and aggression. 2 Furthermore, serotonergic dysfunction has been suggested in suicide based on several observations. For example, low concentration of the metabolite of serotonin (5-HIAA), in CSF has been associated with suicide attempts and completed suicide, 3 and low levels of 5-HT or 5-HIAA were also observed in suicide victims. 4 5-HT is synthesized in two steps, with tryptophan hydroxylase (TPH) as the rate-limiting enzyme. 5 Thus far, two TPH genes have been identified. The TPH1 gene is located on chromosome 11p15 and has been the focus of a number of genetic studies of suicidality. A recent meta-analysis concluded that the TPH1 intron 7 A218 polymorphism is associated with suicide-related behavior. 6 Interestingly, a new TPH gene (TPH2) located on chromosome 12q21 has recently been described. In mice brain stem, expression of TPH1 appears to be 150 times lower than TPH2, suggesting that TPH2 may play a much more important role in serotonin synthesis in the brain than TPH1. 7 Therefore, we were interested in investigating the putative role of the TPH2 gene in suicide attempters using a large and well-characterized sample of patients with bipolar disorder. TPH2 has three highly polymorphic single-nucleotide polymorphisms (SNPs): hCV245410 (C/T), hCV8376173 (A/G), rs1487280 (A/G). These SNPs are located in introns 1, 5, and 8, respectively.
The study population consisted of 336 bipolar patients from 305 families who were recruited in the Toronto area. The mean age at the time of the interview was 35.36710.37 SD. Subjects ranged in age from 16 to 67 years (35710 SD). The mean age at onset for bipolar disorder was 2077.58 SD. Female subjects comprised 62% of the sample. A total of 86 patients attempted suicide. The SCID-I was administered to all subjects by trained clinical interviewers. Suicidality was assessed on a quantitative scale, with the following order: 1 ¼ Thoughts of death, 2 ¼ Suicide Ideation, 3 ¼ Suicide Plan, 4 ¼ Suicide Attempt. Among the bipolar patients, 267 patients had history of suicide ideas or attempt and the mean score for all 336 suicide ideation/behavior scores was 2.171.4.
The genoptypes of TPH2 hCV245410, hCV8376173, and rs1487280 polymorphisms were determined by Taqman assay (ABI 7000). Allelic and haplotype transmission tests in suicide attempters were performed using TDT and TRANSMIT. The Family Based Association Test (FBAT) was used for analyses of suicide ideation/behavior quantitative traits. All the analyses were performed under the assumption of an additive model.
Main results for single marker TDT in attempter patients are shown in Table 1 . For the haplotypes of these three polymorphisms in the attempter population, the TRANSMIT analysis showed a nonsignificant global w 2 (0.56, 5 df). When the suicide behavior was analyzed as a quantitative trait by FBAT, no significant differences were found for hCV245410 (z ¼ 0.051 P ¼ 0.959467), hCV8376173 (z ¼ 0.090 P ¼ 0.928282), and rs1487280 (z ¼ À0.143; P ¼ 0.886). All the eight possible haplotypes showed no significant results when weighted on the suicide behavior as the quantitative trait (Table 2) . In bipolar patients, the TDT did not show significant bias for hCV245410 (109 vs 109 transmissions), hCV8376173 (106 vs 104), and rs1487280 (100 vs 105). The global w 2 using TRANSMIT analyzing only frequent haplotypes was not significant in the overall sample (1.8874, 5 df).
To our knowledge, this is the first association study between the TPH2 gene and bipolar disorder and suicide behavior. Our results indicate that it is unlikely that the hCV245410-hCV8376173-rs1487-280 haplotypes are involved in the suicide behavior in our bipolar sample. The three variants chosen in this study are polymorphic enough to provide good statistical power for this family study design. Moreover, mutation screening of the TPH2 promoter could be very valuable and these 5 0 flanking variants might be involved in suicide behavior because of the prior evidence that the immunoreactivity and the expression of TPH in the brains of suicide patients is higher. 8 Despite the fact that bipolar disorder has been shown to have a strong genetic component 9 and the serotonergic system is implicated in the pathogenesis of the disorder, 10 we found that all haplotypes of the TPH2 gene were without bias to bipolar probands in the total sample.
Although possible biological differences between suicidal ideation and attempted suicide are pointed out in TPH1 association studies where the 218A/C polymorphism was associated with suicide attempt [11] [12] but not with suicide ideation, 13 the main strength of this study is the family-based strategy that is not sensitive to population stratification, the large sample size, and the suicide quantitative trait assessment. On the other hand, the main weakness is that we assessed the suicidal attempters but not suicide completers.
In conclusion, given the relatively small sample size of the suicide attempter group in this study, larger samples are needed in future investigations of the TPH2 gene.
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